Webinar: Understanding the Tumor Immune Composition Using Multiplexed Quantitative Analyses

Missed our live webinar? Catch up on what you missed by watching it on demand. This webinar will examine valid strategies for multiplexed analyses of immune-related protein and mRNA targets in human malignancies. Topics include: approaches for methods standardization, use of multiplexed fluorescence to interrogate the biological role and clinical significance of immune cell populations and immunotherapy targets in cancer.

Development of effective anti-cancer immunotherapies requires careful evaluation of the tumor immune microenvironment. Traditional techniques for tumor analysis, such as chromogenic immunohistochemistry and flow cytometry, have prominent limitations. Multiplexed quantitative fluorescence permits simultaneous detection of diverse targets within FFPE tissue sections, while preserving spatial context and quantitative output. 


Kurt A. Schalper, M.D./Ph.D

Assistant Professor of Pathology and Medicine (Medical Oncology) Director Translational Immuno-oncology Laboratory Yale University

Clifford Hoyt

Oncology Fellow, Director of Applications and Services PerkinElmer, Inc
In this webinar, you can:
  • Understand the advantages and limitations of measuring biomarkers using multiplexed qualitative fluorescence in tumor tissues
  • Explore the current role and future possibilities of using multiplexed/quantitative analyses in immuno-oncology
  • Gain insight on platforms and key parameters for assay validation and standardization

View our webinar on-demand